Diego Martín‐Sánchez

2.0k total citations · 2 hit papers
21 papers, 1.6k citations indexed

About

Diego Martín‐Sánchez is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Diego Martín‐Sánchez has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Nephrology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Diego Martín‐Sánchez's work include Acute Kidney Injury Research (7 papers), Trace Elements in Health (5 papers) and Ferroptosis and cancer prognosis (5 papers). Diego Martín‐Sánchez is often cited by papers focused on Acute Kidney Injury Research (7 papers), Trace Elements in Health (5 papers) and Ferroptosis and cancer prognosis (5 papers). Diego Martín‐Sánchez collaborates with scholars based in Spain, Germany and United States. Diego Martín‐Sánchez's co-authors include Alberto Ortíz, Ana B. Sanz, María Dolores Sánchez-Niño, Marta Ruiz‐Ortega, Miguel Fontecha‐Barriuso, Susana Carrasco, Jesús Egido, Olga Ruiz‐Andrés, Pablo Cannata‐Ortiz and Jonay Poveda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and The FASEB Journal.

In The Last Decade

Diego Martín‐Sánchez

20 papers receiving 1.6k citations

Hit Papers

Ferroptosis, but Not Necroptosis, Is Important in Nephrot... 2016 2026 2019 2022 2016 2020 100 200 300 400

Peers

Diego Martín‐Sánchez
Diego Martín‐Sánchez
Citations per year, relative to Diego Martín‐Sánchez Diego Martín‐Sánchez (= 1×) peers Pablo Cannata‐Ortiz

Countries citing papers authored by Diego Martín‐Sánchez

Since Specialization
Citations

This map shows the geographic impact of Diego Martín‐Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Martín‐Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Martín‐Sánchez more than expected).

Fields of papers citing papers by Diego Martín‐Sánchez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Martín‐Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Martín‐Sánchez. The network helps show where Diego Martín‐Sánchez may publish in the future.

Co-authorship network of co-authors of Diego Martín‐Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Martín‐Sánchez. A scholar is included among the top collaborators of Diego Martín‐Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Martín‐Sánchez. Diego Martín‐Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fontecha‐Barriuso, Miguel, Julio M. Martínez‐Moreno, Susana Carrasco, et al.. (2024). Runt‐related transcription factor 1 ( RUNX1 ) is a mediator of acute kidney injury. The Journal of Pathology. 264(4). 396–410.
2.
Martín‐Sánchez, Diego, Olatz Fresnedo, Manuel J. Gómez, et al.. (2022). Ferrostatin‐1 modulates dysregulated kidney lipids in acute kidney injury. The Journal of Pathology. 257(3). 285–299. 24 indexed citations
3.
Martínez‐Moreno, Julio M., María Vanessa Pérez-Gómez, Diego Martín‐Sánchez, et al.. (2021). TWEAK Signaling Pathway Blockade Slows Cyst Growth and Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology. 32(8). 1913–1932. 24 indexed citations
4.
Benavente, R. Cabello, Miguel Fontecha‐Barriuso, Diego Martín‐Sánchez, et al.. (2021). Urinary Cyclophilin A as Marker of Tubular Cell Death and Kidney Injury. Biomedicines. 9(2). 217–217. 13 indexed citations
5.
Martínez‐Moreno, Julio M., Miguel Fontecha‐Barriuso, Diego Martín‐Sánchez, et al.. (2020). The Contribution of Histone Crotonylation to Tissue Health and Disease: Focus on Kidney Health. Frontiers in Pharmacology. 11. 393–393. 30 indexed citations
6.
Martín‐Sánchez, Diego, Miguel Fontecha‐Barriuso, Julio M. Martínez‐Moreno, et al.. (2020). Ferroptosis and kidney disease. Nefrología. 40(4). 384–394. 70 indexed citations
7.
Fontecha‐Barriuso, Miguel, Diego Martín‐Sánchez, Julio M. Martínez‐Moreno, et al.. (2020). Molecular pathways driving omeprazole nephrotoxicity. Redox Biology. 32. 101464–101464. 46 indexed citations
8.
Fontecha‐Barriuso, Miguel, Diego Martín‐Sánchez, Julio M. Martínez‐Moreno, et al.. (2020). The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases. Biomolecules. 10(2). 347–347. 195 indexed citations breakdown →
9.
Martín‐Sánchez, Diego, Miguel Fontecha‐Barriuso, Julio M. Martínez‐Moreno, et al.. (2020). Ferroptosis and kidney disease. Nefrología (English Edition). 40(4). 384–394. 22 indexed citations
10.
Martínez‐Moreno, Julio M., Miguel Fontecha‐Barriuso, Diego Martín‐Sánchez, et al.. (2020). Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease. International Journal of Molecular Sciences. 21(11). 4113–4113. 52 indexed citations
11.
Fontecha‐Barriuso, Miguel, Diego Martín‐Sánchez, Julio M. Martínez‐Moreno, et al.. (2019). PGC‐1α deficiency causes spontaneous kidney inflammation and increases the severity of nephrotoxic AKI. The Journal of Pathology. 249(1). 65–78. 88 indexed citations
12.
García‐Caballero, Cristina, Alejandra Palomino‐Antolín, Alfonso Rubio‐Navarro, et al.. (2019). FP282FERROPTOSIS-MEDIATED CELL DEATH IS DECREASED BY CURCUMIN IN RENAL DAMAGE ASSOCIATED TO RHABDOMYOLYSIS. Nephrology Dialysis Transplantation. 34(Supplement_1). 1 indexed citations
13.
Guerrero‐Hue, Melania, Cristina García‐Caballero, Alejandra Palomino‐Antolín, et al.. (2019). Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis‐mediated cell death. The FASEB Journal. 33(8). 8961–8975. 211 indexed citations
14.
Martín‐Sánchez, Diego, Miguel Fontecha‐Barriuso, Susana Carrasco, et al.. (2018). TWEAK and RIPK1 mediate a second wave of cell death during AKI. Proceedings of the National Academy of Sciences. 115(16). 4182–4187. 118 indexed citations
15.
Martín‐Sánchez, Diego, Miguel Fontecha‐Barriuso, María Dolores Sánchez-Niño, et al.. (2018). Cell death-based approaches in treatment of the urinary tract-associated diseases: a fight for survival in the killing fields. Cell Death and Disease. 9(2). 118–118. 24 indexed citations
16.
Fontecha‐Barriuso, Miguel, Diego Martín‐Sánchez, Olga Ruiz‐Andrés, et al.. (2018). Targeting epigenetic DNA and histone modifications to treat kidney disease. Nephrology Dialysis Transplantation. 33(11). 1875–1886. 98 indexed citations
17.
Martín‐Sánchez, Diego, Jonay Poveda, Miguel Fontecha‐Barriuso, et al.. (2017). Targeting of regulated necrosis in kidney disease. Nefrología. 38(2). 125–135. 40 indexed citations
18.
Martín‐Sánchez, Diego, Miguel Fontecha‐Barriuso, Susana Carrasco, et al.. (2017). Deferasirox-induced iron depletion promotes BclxL downregulation and death of proximal tubular cells. Scientific Reports. 7(1). 41510–41510. 28 indexed citations
19.
Martín‐Sánchez, Diego, Olga Ruiz‐Andrés, Jonay Poveda, et al.. (2016). Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid–Induced AKI. Journal of the American Society of Nephrology. 28(1). 218–229. 445 indexed citations breakdown →
20.
Hénaut, Lucie, Ana B. Sanz, Diego Martín‐Sánchez, et al.. (2016). TWEAK favors phosphate-induced calcification of vascular smooth muscle cells through canonical and non-canonical activation of NFκB. Cell Death and Disease. 7(7). e2305–e2305. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026